tinyurl.com
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis | NEJM
For decades, poor treatment options and low-quality evidence plagued care for patients
with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis
and enhanced funding now p...